Bosentan Hydrate

CAS No. 157212-55-0

Bosentan Hydrate( —— )

Catalog No. M12244 CAS No. 157212-55-0

Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 35 In Stock
50MG 50 In Stock
100MG 87 In Stock
200MG 147 In Stock
500MG 267 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bosentan Hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
  • Description
    Bosentan is a competitive and dual antagonist of endothelin-1 at the endothelin-A (ET-A) and endothelin-B (ET-B) receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Endothelin Receptor
  • Recptor
    ET-B| ET-A
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    157212-55-0
  • Formula Weight
    569.63
  • Molecular Formula
    C??H??N?O?S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:93 mg/mL (163.3 mM);Ethanol:2 mg/mL (3.51 mM);Water:<1 mg/Ml
  • SMILES
    O.COC1=CC=CC=C1OC1=C(OCCO)N=C(N=C1NS(=O)(=O)C1=CC=C(C=C1)C(C)(C)C)C1=NC=CC=N1 |c:4,6,10,16,18,27,29,38,40,t:2,25,36|
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Clozel M, et al. J Pharmacol Exp Ther, 1994, 270(1), 228-235.
molnova catalog
related products
  • Atrasentan hydrochlo...

    Atrasentan hydrochloride is an antagonist of the endothelin receptor(IC50 = 55.1 μM for ETA).

  • Sarafotoxin S6c

    Highly selective ETB endothelin receptor agonist (Ki values are 0.29 and 28000 nM at ETB and ETA receptors respectively).

  • Ambrisentan

    Ambrisentan (BSF 208075;LU 208075) is a highly selective antagonist of the endothelin-1 type A receptor (ETA) for use in the treatment of pulmonary hypertension.